Synthesis and transdermal penetration of cytarabine and selected amide, ester and carbamate derivatives

作者: Lesetja Jan Legoabe

DOI:

关键词:

摘要: Cancer is reported to be one of the top ten leading causes death worldwide and its treatment poses a number challenges. Cytarabine deoxycytidine analogue commonly used in haematological malignant diseases. Its clinical utility, however, severely limited by short plasma half-life due catabolic action nucleoside deaminases. Due cell cycle (S-phase) specificity cytarabine, prolonged exposure cells cytarabine's cytotoxic concentrations essential achieve maximum activity often achieved more invasive inconvenient modes administration such as continuous intravenous infusion. Transdermal drug delivery systems (TO OS), on other hand, have potential this sustained release which useful for drugs with biological half-lives without inconvenience associated However, not .all are suited TDDS. Owing good barrier function skin mainly lipophilic outermost layer, stratum corneum, most hydrophilic structures permeate too slowly therapeutic benefit. This hydrogen-bonding functionality permeant drastically retard permeation. known high hydrophilicity plurality polar functional groups capable hydrogen bonding. Therefore, it becomes apparent that cytarabine would easily skin. The disadvantages TDDS include irritation, possible side effects. Prodrug approach could circumvent these setbacks. has been investigated enhance dermal transdermal penetration unfavourable intrinsic properties showed promising outcomes. Increased if delivered via derivative better physicochemical penetration. aims study were determine synthesized amide, ester carbamate derivatives establish correlation, any, between selected properties. alkylamide (5 compounds), alkylester (6 compounds) Compounds) standard chemical procedures, their confirmed NMR MS they evaluated using human epidermis model. flux values determined vitro Franz diffusion methodology. Quantification compounds was HPLC. Selected (aqueous lipid solubility; melting point log D) assessed any correlation parameters compounds.

参考文章(29)
Kenneth B. Sloan, Scott C. Wasdo, Topical Delivery Using Prodrugs Prodrugs. pp. 83- 123 ,(2007) , 10.1007/978-0-387-49785-3_3
Michael Kluge, Herbert Schott, Cytarabine derivatives, the preparation and use thereof ,(1994)
Shigeru Tsukagoshi, Yoshio Sakurai, Hidehiko Kobayashi, Torao Ishida, Jun-ichi Oh-ishi, Michiko Aoshima, N4-Behenoyl-1-β-d-arabinofuranosylcytosine as a Potential New Antitumor Agent Cancer Research. ,vol. 37, pp. 2481- 2486 ,(1977)
P. A. Cassileth, R. P. Gale, Brian James Bolwell, High dose cytarabine: a review. Leukemia. ,vol. 2, pp. 253- 260 ,(1988)
Emil Frei, James S. Hewlett, Montague Lane, Robert W. Talley, John N. Bickers, William V. Leary, Dose Schedule and Antitumor Studies of Arabinosyl Cytosine (NSC 63878) Cancer Research. ,vol. 29, pp. 1325- 1332 ,(1969)
Hammed M. Abdou, Dissolution, Bioavailability and Bioequivalence Drug Development and Industrial Pharmacy. ,vol. 16, pp. 185- 186 ,(1990) , 10.3109/03639049009115995
Carmelo Puglia, Rosanna Filosa, Antonella Peduto, Paolo de Caprariis, Luisa Rizza, Francesco Bonina, Paolo Blasi, Evaluation of alternative strategies to optimize ketorolac transdermal delivery Aaps Pharmscitech. ,vol. 7, pp. 64- 64 ,(2006) , 10.1208/PT070364
Aarti Naik, Yogeshvar N. Kalia, Richard H. Guy, Transdermal drug delivery: overcoming the skin's barrier function. Pharmaceutical Science & Technology Today. ,vol. 3, pp. 318- 326 ,(2000) , 10.1016/S1461-5347(00)00295-9
F.P. Bonina, L. Montenegro, P. De Caprariis, F. Palagiano, G. Trapani, G. Liso, In vitro and in vivo evaluation of polyoxyethylene indomethacin esters as dermal prodrugs Journal of Controlled Release. ,vol. 34, pp. 223- 232 ,(1995) , 10.1016/0168-3659(95)00003-Q
M. BODÁNSZKY, Synthesis of peptides by aminolysis of nitrophenyl esters. Nature. ,vol. 175, pp. 685- 685 ,(1955) , 10.1038/175685A0